RP-HPLC method development and validation for bedaquiline fumarate to evaluate its forced degradation behaviour and stability in official dissolution media

Abstract Background A simple, rapid and accurate reverse phase RP-HPLC method for the validation of antitubercular drug bedaquiline fumarate (BQF) was developed. The stability and forced degradation behaviour of bedaquiline fumarate (BQF) in official dissolution media (0.01 N HCl) and methanol were...

Full description

Saved in:
Bibliographic Details
Main Authors: Vishwas Pardhi (Author), Geetanjali Pant (Author), S. J. S. Flora (Author)
Format: Book
Published: SpringerOpen, 2020-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_ea9d1b9a09d444898929b83f89d10f4e
042 |a dc 
100 1 0 |a Vishwas Pardhi  |e author 
700 1 0 |a Geetanjali Pant  |e author 
700 1 0 |a S. J. S. Flora  |e author 
245 0 0 |a RP-HPLC method development and validation for bedaquiline fumarate to evaluate its forced degradation behaviour and stability in official dissolution media 
260 |b SpringerOpen,   |c 2020-07-01T00:00:00Z. 
500 |a 10.1186/s43094-020-00061-x 
500 |a 2314-7253 
520 |a Abstract Background A simple, rapid and accurate reverse phase RP-HPLC method for the validation of antitubercular drug bedaquiline fumarate (BQF) was developed. The stability and forced degradation behaviour of bedaquiline fumarate (BQF) in official dissolution media (0.01 N HCl) and methanol were assessed. Results The method provided linear responses within the concentration range which varies from 10 to 100 μg/mL with LOD values of 2.6 μg/mL and LOQ of 7.9 μg/mL. Mean percent recovery varied between 97.46 and 103.82% and precise mean RSD of 0.31% (repeatability) and 0.48% (intermediate precision). The method was validated for other parameters like specificity, system suitability and robustness. Potential degradation of the BQF when exposed to direct sunlight in official dissolution media was 90.75% and in methanolic stock solution was 91.98%. Acid-alkali degradation study showed 86.59% loss of BQF in 0.5 N NaOH, and in acidic environment (0.5 N HCl), there was 6.15% loss. Thermal degradation of BQF was 70.11% loss in official dissolution media at 80 °C. No significant change in drug concentrations was noted when exposed and protected from normal daylight at room temperature and at 2-8 °C temperature. Conclusion The developed method has significant applicability for the qualitative and quantitative determination of BQF in different pharmaceutical formulations in the official dissolution media in routine quality control analysis. 
546 |a EN 
690 |a Antitubercular 
690 |a Bedaquiline fumarate 
690 |a Accuracy 
690 |a Precision 
690 |a Stability 
690 |a Hydrolytic degradation 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Future Journal of Pharmaceutical Sciences, Vol 6, Iss 1, Pp 1-10 (2020) 
787 0 |n http://link.springer.com/article/10.1186/s43094-020-00061-x 
787 0 |n https://doaj.org/toc/2314-7253 
856 4 1 |u https://doaj.org/article/ea9d1b9a09d444898929b83f89d10f4e  |z Connect to this object online.